Schroder Investment Management Group
SCLN

Schroder Investment Management Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Schroder Investment Management Group’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,700
Closed -$18.8K – 1605
2013
Q3 		$18.8K Sell
3,700
-2,042,696
-100% -$11.4M ﹤0.01% 1411
2013
Q2 		$10.2M Buy
+2,046,396
New +$9.74M 0.03% 580

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schroder Investment Management Group's SCLN Position: Q4 2013 in Review

Schroder Investment Management Group sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2013, closing a stake of 3,700 shares — an estimated $18.8K sold.

Schroder Investment Management Group first reported a position in SCLN in Q2 2013 and held it in 2 quarters. The position peaked at $10.2M in Q2 2013. 100 funds tracked by Wall St. Rank hold SCLN as of Q4 2013.

  • Schroder Investment Management Group reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Schroder Investment Management Group sold 3,700 Sciclone Pharmaceuticals Inc shares in Q4 2013, an estimated $18.8K.
  • Schroder Investment Management Group first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Schroder Investment Management Group's Sciclone Pharmaceuticals Inc position peaked at $10.2M in Q2 2013.
  • 100 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2013.

Based on Schroder Investment Management Group's 13F filing for Q4 2013, filed 14 Feb 2014.